Searched for
PHARMEASY
Pharmeasy-parent’s loss narrows in Q1, revenue up 10%API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while reven...- ISM outlay faces currency pressure; ETSA 2026 Best on Campus, Comeback Kid nomineesA weak rupee has dragged down the dollar value of the India Semiconductor Mission subsidies. This and more in today’s ETtech Top 5.
- Pharmeasy founder says failure to deleverage was key reason for debt sagaSiddharth Shah’s comments came a day after API Holdings repaid Rs 1,050 crore of debt, becoming debt-free after years of pressure on its ba...
- Pharmeasy parent clears Rs 1,050 crore debt, frees Thyrocare stake from pledgeThe debt repayment marks the latest step in API Holdings’ efforts to clean up its balance sheet after a difficult period struggling to rais...
- Feeling hot and sweaty and experiencing painful urine? Nutritionist shares easy and delicious solution to your problems. All the ingredients are readily available in your kitchenSuffering from excessive heat in your body and having issues such as painful urine and UTIs as a woman? A nutritionist has shared the recip...
- Investing before an IPO: As NSE, Jio Platforms prepare to list, five early investors reveal the rewards, risks, and patience requiredET Wealth spoke to five investors who bought NSE shares long before the IPO became a certainty. Their stories are a reminder of the opportu...
- Fundamentum launches Rs 2,200 crore growth fund with Nandan Nilekani as anchor LPNandan Nilekani will be anchoring Fundamentum Fund III with what the firm described as his largest investment in a venture capital firm. Th...
- Global creditors drag Udaan's parent to bankruptcy court in Singapore after $170-million bond defaultInsolvency petition filed this week, A&M appointed as liquidator of B2B commerce company. Ten year old co has seen valuations crash 70% as ...
- Uber India head ends trip; Amazon CEO on India opportunityUber's India head Prabhjeet Singh has stepped down after 11 years at the platform. This and more in today's ETtech Top 5.
- Pharmeasy founders’ new venture All Home raises Rs 200 crore; valuation doublesAll Home, which operates in the interior design and architecture space, partners with brands by investing in them and providing capabilitie...
- PharmEasy’s FY23 operating revenue up 16% to Rs 6,644 crore; net loss widens 30%PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred ...
- Exclusive: PharmEasy plans Rs 2,400-crore rights issue at 90% discount to repay loanMumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021
- Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
- PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
- PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...
- PharmEasy closes pre-IPO funding round at $5.6 billion valuationPharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...
- PharmEasy parent API Holdings strengthens board ahead of IPOAPI Holdings — the parent company of PharmEasy — has appointed five independent directors to its board. India's biggest online pharmacy is ...
- Pharmeasy in funding talks with SoftBank after Thyrocare dealPharmeasy’s parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million ...
- ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
- PharmEasy completes acquisition of MedlifeThe company has now become the largest healthcare delivery platform across the country, catering to more than two million families every si...
Load More
